Maisha Meds, a pioneering digital health organization in Africa, received US$5.25 million in scale-up stage 3 funding from USAID’s Development Innovation Ventures (DIV).
Over the course of three years, Maisha Meds will use the US$5.25 million in funding from DIV to support its expansion efforts. Across Africa, private pharmacies, drug stores, and clinics often serve as the first — and sometimes the only — point of care for individuals in need of high-quality, reasonably priced malaria care.
Using the Maisha Meds platform, rural pharmacies and clinics may more efficiently stock up on low-cost, high-quality medicine and distribute patient subsidies.
According to Dr. Jessica Vernon, founder, and CEO of Maisha Meds, “Frontline pharmacies provide the bulk of malaria care across many parts of Africa outside of the formal health system, and technology can play an important role in improving the quality of care that they provide.”
“We are thrilled that USAID DIV has provided additional support to scale our innovation in partnership with governments and pharmacy owners,” Vernon added.
The DIV’s highest financing level, known as stage 3 grants, assists innovators in scaling up tested, economical solutions to pressing global issues. Maisha Meds uses partner funding to encourage medical professionals to treat patients with malaria adhering to best practices and giving patients affordable testing and treatment. It provides similar assistance with HIV prevention and family planning.
Maisha Meds intends to reach 7,500 pharmacies and clinics with its mobile software by the end of the grant period, providing discounted care to around a million patients, thanks to further backing from the Bill & Melinda Gates Foundation.
Read more on Tech Gist Africa:
Lipa Later, a Kenyan fintech startup has secured $3.4 million in debt funding
Kotani, a Kenyan crypto payment startup, has closed a $2 million pre-seed funding round.
FlexPay, a Kenyan fintech company, receives investment from Renew Capital Angels
Comments 1